$セラピューティクスMD(TXMD.US)$ See some improvements in earnings but most importantly why I’ve got my attention here is the following statement from the company! ( said that it is exploring strategic alternatives for the company, which could include a business combination or sale of assets. ) Would love to see a big Pharma swoop in a buy! Thats why it has my attention!
![]()
The company also released its Q3 financial report, posting a net loss from continuing operations of $0.13 per share...